ATX — Amplia Therapeutics Share News
0.000.00%
- AU$40.53m
- AU$13.02m
Australia Stock Exchange release from AMPLIA THERAPEUT : Proposed issue of securities - ATX
Australia Stock Exchange release from AMPLIA THERAPEUT : Update - Application for quotation of securities - ATX
Australia Stock Exchange release from AMPLIA THERAPEUT : Results of Extraordinary General Meeting
Australia Stock Exchange release from AMPLIA THERAPEUT : PRE_NR Ends: 10:03:22
Australia Stock Exchange release from AMPLIA THERAPEUT : Amplia Provides Updated Investor Presentation
Australia Stock Exchange release from AMPLIA THERAPEUT : Change in substantial holding
Australia Stock Exchange release from AMPLIA THERAPEUT : Update - Application for quotation of securities - ATX
Australia Stock Exchange release from AMPLIA THERAPEUT : Update - Proposed issue of securities - ATX
Australia Stock Exchange release from AMPLIA THERAPEUT : Entitlement Offer Completed
Australia Stock Exchange release from AMPLIA THERAPEUT : PRE_NR Ends: 11:37:51
Australia's Amplia Therapeutics marks best day in 1 week on funding facility
Australia Stock Exchange release from AMPLIA THERAPEUT : PRE_NR Ends: 11:21:55
Australia Stock Exchange release from AMPLIA THERAPEUT : Amplia Awarded $2.1M R&D Cash Flow Loan
Australia Stock Exchange release from AMPLIA THERAPEUT : PRE_NR Ends: 16:56:27
Australia Stock Exchange release from AMPLIA THERAPEUT : App 4D and Financial Report Half Year ended 30 Sep 2021
Australia Stock Exchange release from AMPLIA THERAPEUT : Notice of Extraordinary General Meeting - 17 Dec 2021
Brief: Amplia Therapeutics Says Results From Phase 1 Trial Confirm Amp945 Is Safe And Well Tolerated
Australia Stock Exchange release from AMPLIA THERAPEUT : Summary Results - Successful Phase 1 Clinical Trial AMP945
Australia Stock Exchange release from AMPLIA THERAPEUT : PRE_NR Ends: 08:36:20